Caspofungin in kidney transplant recipients with refractory invasive candidiasis

Nephrol Dial Transplant. 2007 May;22(5):1487-9. doi: 10.1093/ndt/gfl749. Epub 2007 Jan 8.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Candidiasis / drug therapy*
  • Candidiasis / etiology
  • Caspofungin
  • Drug Resistance, Fungal
  • Echinocandins
  • Esophagus / microbiology
  • Fluconazole / therapeutic use
  • Humans
  • Kidney Transplantation / adverse effects*
  • Lipopeptides
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology
  • Opportunistic Infections / microbiology
  • Peptides, Cyclic / adverse effects
  • Peptides, Cyclic / therapeutic use*
  • Urinary Tract / microbiology

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Fluconazole
  • Caspofungin